Blood pressure drug limits cigarette smoke-induced lung injury in mice

Chronic obstructive pulmonary disease (COPD) is among the most common causes of death in the US. It is a smoking-related disease for which there are currently no disease-altering therapies. However, hope that one could be developed is now provided by the work of Enid Neptune and colleagues, at Johns Hopkins University, Baltimore, in a mouse model of lung disease caused by exposure to cigarette smoke.

Neptune and colleagues found that lostartan, a drug used widely in the clinic (e.g., to treat ), reduced lung disease in mice caused by exposure to .

Losartan blocks the protein angiotensin receptor type 1, and its effects on cigarette smoke–induced lung injury were a result of the fact that blocking angiotensin receptor type 1 leads to a decrease in levels of the soluble molecule TGF-beta.

The authors therefore suggest that other TGF-beta–targeted therapeutics might also be viable candidates for the treatment of COPD.

More information: Angiotensin receptor blockade attenuates cigarette smoke–induced lung injury and rescues lung architecture in mice, Journal of Clinical Investigation.

Related Stories

Addressing how cigarettes cause cardiovascular disease

date Oct 10, 2011

Although cigarette smoking has long been linked to cardiovascular disease, scientists are still on the lookout for insights into how smoking causes this disease. A team of researchers at Pacific Northwest ...

Body's defenses may worsen chronic lung diseases in smokers

date Feb 09, 2009

Although the immune system is designed to protect the body from harm, it may actually worsen one of the most difficult-to-treat respiratory diseases: chronic obstructive pulmonary disorder (COPD), according to new University ...

New technique reduces tobacco smoke damage to lungs in mice

date Mar 18, 2010

Researchers in Australia have demonstrated that blocking a certain protein can reduce or prevent cigarette smoke-induced lung inflammation in mice. Inflammation underlies the disease process of chronic obstructive pulmonary ...

Recommended for you

Novel nanoparticle therapy promotes wound healing

date Mar 26, 2015

An experimental therapy developed by researchers at Albert Einstein College of Medicine of Yeshiva University cut in half the time it takes to heal wounds compared to no treatment at all. Details of the therapy, ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.